KRT19 and hepatocellular carcinoma: Clinical data show that 4–28% of HCC patients exhibit CK19-positive expression, and these cases are often accompanied by high AFP expression, hepatitis B virus positivity, and more aggressive biological behavior, leading to significantly reduced overall survival and recurrence-free survival (RFS) rates [13, 14].